Weekly Research Analysts’ Ratings Updates for Savaria (SIS)

Savaria (TSE: SIS) recently received a number of ratings updates from brokerages and research firms:

• 3/6/2026 – Savaria had its price target raised by ATB Cormark Capital Markets from C$30.00 to C$32.00. They now have an “outperform” rating on the stock.
• 3/6/2026 – Savaria had its price target raised by Scotiabank from C$29.00 to C$30.00. They now have an “outperform” rating on the stock.
• 3/6/2026 – Savaria had its price target raised by Raymond James Financial, Inc. from C$27.00 to C$32.00. They now have an “outperform” rating on the stock.
• 3/6/2026 – Savaria had its price target raised by National Bank Financial from C$30.00 to C$30.50. They now have an “outperform” rating on the stock.
• 3/6/2026 – Savaria had its price target raised by Desjardins from C$27.00 to C$32.00. They now have a “buy” rating on the stock.
• 3/6/2026 – Savaria had its price target raised by Stifel Nicolaus from C$28.00 to C$29.00. They now have a “buy” rating on the stock.
• 3/5/2026 – Savaria had its price target raised by TD Securities from C$27.00 to C$31.00. They now have a “buy” rating on the stock.

Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.